Cisplatin/Paclitaxel vs Cisplatin/Teniposide for Advanced Non-Small-Cell Lung Cancer

ONCOLOGY

Volumn 11, Issue 4 SUPPL. 3, 1997, Pages 11-14

  Giaccone, Giuseppe ^a,i   Postmus, Piet E ^a   Splinter, Ted A W ^b   Diaz Puente, Maria ^c   Van Zandwijk, Nico ^d   Scagliotti, Giorgio ^e   Ardizzoni, Andrea ^f   Van Meerbeeck, Jan ^g   Debruyne, Channa ^h   Sahmoud, Tarek ^h  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e SAN LUIGI GONZAGA HOSPITAL   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^h EORTC DATA CENTER   (Belgium)

ⁱ VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PACLITAXEL; TENIPOSIDE;

ADULT; AGED; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PACLITAXEL; SURVIVAL; TENIPOSIDE; TREATMENT OUTCOME;

EID: 0030769069     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Giaccone G: New drugs in non-small cell lung cancer, an overview Lung Cancer 12(suppl 1):S155-S162, 1995.
2. Splinter TAW, Sahmoud T, Festen J, et al: Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: A randomized study of the EORTC lung cancer cooperative group. J Clin Oncol 14:127-134, 1996.
3. Slevin MC, Clark PI, Joel JP, et al: A randomized trial to evaluate the effect of schedule on the activity of etoposide in small cell lung cancer. J Clin Oncol 7:1333-1340, 1989.
4. Rowinsky EK, Gilbert MR, McGuire WP, et al: Sequence of taxol and cisplatin: A phase I and pharmacologic study, J Clin Oncol 9:1692-1703, 1991
5. Eisenhauer EA, ten Bokkel Huinink WW, Swenerton KD, et al: European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer. High-dose versus low-dose and long versus short infusion. J Clin Oncol 12:2654-2666, 1994
6. Postmus PE, Giaccone G, Debruync C, et al: Results of the phase II EORTC study comparing paclitaxel/cisplatin with teniposide/cisplatin in patients with non-small cell lung cancer. Semin Oncol 23(suppl 12)10-13, 1996.